Biological approaches to the repair and regeneration of the rotator cuff tendon-bone enthesis: a literature review
Entheses are highly specialised organs connecting ligaments and tendons to bones, facilitating force transmission, and providing mechanical strengths to absorb forces encountered. Two types of entheses, fibrocartilaginous and fibrous, exist in interfaces. The gradual fibrocartilaginous type is in rotator cuff tendons and is more frequently injured due to the poor healing capacity that leads to loss of the original structural and biomechanical properties and is attributed to the high prevalence of retears. Fluctuating methodologies and outcomes of biological approaches are challenges to overcome for them to be routinely used in clinics. Therefore, stratifying the existing literature according to different categories (chronicity, extent of tear, and studied population) would effectively guide repair approaches. This literature review supports tissue engineering approaches to promote rotator cuff enthesis healing employing cells, growth factors, and scaffolds period. Outcomes suggest its promising role in animal studies as well as some clinical trials and that combination therapies are more beneficial than individualized ones. It then highlights the importance of tailoring interventions according to the tear extent, chronicity, and the population being treated. Contributing factors such as loading, deficiencies, and lifestyle habits should also be taken into consideration. Optimum results can be achieved if biological, mechanical, and environmental factors are approached. It is challenging to determine whether variations are due to the interventions themselves, the animal models, loading regimen, materials, or tear mechanisms. Future research should focus on tailoring interventions for different categories to formulate protocols, which would best guide regenerative medicine decision making.
Introduction
Entheses are highly specialised interfaces between fibrous isotropic tendons and ligaments (elastic modulus = 450 MPa axially) that provide tensile strength, and rigid inelastic isotropic bones (elastic modulus = 20 GPa) that optimise compressive loads, facilitating joint motion.1 Entheses evolved highly specialised structures that effectively dampen the forces encountered in the region of peak strain, to facilitate seamless stress transfer and prevent tendon avulsion; whilst maintaining effective communication between tendons and bones to preserve homeostasis.2⇓-4 This heterogenous interface is unique and owing to its complexity and propensity to heal with biomechanically inferior scar tissue, presents significant challenges to repair and regeneration.
Rotator cuff (RC) tears are common with an increasing prevalence of partial and full thickness tears after the age of 50, and a 90% surgical repair failure.5⇓-7 The capacity to repair the damaged enthesis is insufficient, because of the tissue's lack of regeneration, leading to scar formation with inferior mechanical properties at the repair site.8 Trials to enhance the healing progress of the RC enthesis have been directed towards regenerative methods.7 To date, there are no records of a single successful clinical biological approach achieving an enhanced healing of the injured enthesis. This review investigates the potential use of tailored biological therapies in different RC tear mechanisms, chronicity, and populations treated.
Entheses types
Histologically, there are two types of entheses classified according to the presence or absence of fibrocartilage, Fibrocartilaginous and Fibrous. Fibrous entheses insert via collagen fibres at the metaphysis or diaphysis to dissipate load over a large area, such as the deltoid and the medial collateral ligament, while fibrocartilaginous are at the epiphyses of long bones, such as the RC and Achilles tendons.9,10 The fibrocartilage of fibrocartilaginous entheses is not distributed evenly throughout the interface; appearing thickest in the deepest layers and absent superficially, consistent with the highest stress distribution.11,12 Fibrocartilaginous entheses, such as the RC, are more commonly injured and will therefore be the focus of this review.13
Entheses microstructure
Fibrocartilaginous entheses comprise four layers: dense fibrous tendon, fibrocartilage, mineralised fibrocartilage, and bone. The layers gradually increase in stiffness from tendon to bone to distribute forces over wider surface areas. The first level is composed of organised parallel appearance of collagen I and low levels of Proteoglycans within interspaced elongated tendon fibroblasts. The non-mineralised layer is populated with rows of round fibrochondrocytes embedded in a collagen II- and III-rich extracellular matrix (ECM), and low levels of collagen X, proteoglycans, and glycosaminoglycans. The fibrocartilage and mineralised fibrocartilage regions are separated by a tide mark. The mineralised fibrocartilage merges into bone, which consists of osteoblasts, osteocytes, and osteoclasts, alongside collagen I and a 69% elevated mineral content of which 99% is hydroxyapatite.14
The progressive structure and composition of entheses allow minimisation of the mechanical vulnerability that would arise due to the large elastic modulus mismatch. The structural and mechanical properties of entheses are a result of mechanical loading that have an essential role in enthesis maturation, allowing load transmission and stress reduction.14 This highlights the importance of developing repair solutions that mimic the native biological and mechanical integration of entheses.
Entheses mechanical properties
Force transmission via the enthesis dynamically involves fibre realignment, crimp deformation, and sliding, which are essential for remodelling and turnover. Fibrocartilage enthesis acts like a stretch break that limits tendon narrowing at the insertion, which is a region of stress concentration, hence tendons cross-sectional area increases as they insert into the bone.15,16 The unmineralised region resists compression, while the mineralised resists shearing, creating a two-layered protective component.17 Levels of unmineralised fibrocartilage are higher at entheses with more varied ranges of insertion angles, highlighting its functional role. The mineralised fibrocartilage attachment into bone is rather atypical, providing entheses with varied mechanical integrity.14 Owing to the complex structure of the enthesis; when damaged, it is extremely challenging to repair surgically. The functionally gradual layers are not restored after repairs and the subsequent healing process.2,18,19
Entheses embryological development
Embryologically, it has been hypothesised that initially hyaline cartilage at the enthesis exists alone, and tendons attach to it. The cartilage erodes from the bone and is replaced by the fibrocartilaginous enthesis akin to a growth plate. This emphasises the fibrocartilaginous enthesis development within the tendon.20,21 In utero, the enthesis is originally organised as an unmineralised cartilaginous unit that is mineralised postnatally by endochondral ossification.22⇓-24 Transcription factors, such as SRY-box 9, have been found essential for chondrogenesis, and others for tenogenesis such as mohawk and scleraxis.25⇓-27 Scleraxis knockout mice demonstrated a lower bone mineral density, decreased attachment strength, and disorganised collagen fibres.23,28 Growth factors (GFs), such as transforming growth factor-beta (TGF-β) and bone morphogenetic protein (BMP) are regulators in early enthesis formation, and molecules such as Indian hedgehog (Ihh) and parathyroid hormone-related protein regulate late mineralisation.22,23,29⇓ - 31 During early development, enthesis progenitor cells proliferate and lengthen it, and express collagen I. Stimulated by BMP-4 and Ihh, at the base of the developing enthesis, the cells differentiate into unmineralised fibrochondrocytes, and express collagen I and II. By stimulation of Ihh at the postnatal stage, fibrochondrocytes undergo hypertrophic differentiation at the base of the enthesis. As the mineralised fibrochondrocytes form, collagen X and alkaline phosphate are expressed.32
Since tissue distortion and decreased mineralisation are seen in paralysed mice models, muscle loading is essential for the developing enthesis maturation alongside molecular components.33⇓-35 Disordered cell patterns and lack of enthesis regional transition are effects of reduced muscular stress during development.36,37 A balance between GFs and mechanical stimulation gives rise to the mature complex enthesis structure and composition.
Rotator cuff enthesis and scar tissue
High rates of RC retears are well documented, where various improved suture techniques have been ineffective in reducing them.38 Surgical repairs for RC tears are often performed via a single or double row suture technique with the aim of approximating the ruptured soft tissue segment from bone. However, due to factors such as age, tear chronicity, and poor vascularity, high retear rates persist with scar-mediated tissue of disorganised matrix and inferior mechanical properties forms.7,19,39⇓⇓ -42 Scar formation is thought to be a result of TGF-β1 production by macrophages during the inflammatory phase, leading to fibroblast recruitment.43 Since expression of TGF-β is elevated at injured entheses, it increases collagen I and III deposition and inhibits chondrogenic differentiation.19
Factors influencing healing
Despite better outcomes being linked to intact repairs, it does not guarantee patient satisfaction with functional outcomes.44,45 Variables affecting outcomes of RC repairs include (I) Age: decrease in turnover, fatty infiltration and tear retraction are thought to be the cause for altering the enthesis healing in older populations regardless of the surgical procedure used.46⇓⇓⇓⇓-51 (II) Muscle atrophy: severe pre-operative atrophy and fatty infiltration were linked to lower post-operative repair integrity.45,52,53 (III) Smoking: nicotine has been linked to impairments in biomechanical properties and delayed healing.54 (IV) Diabetes and hypercholesterolemia: they have shown to reduce RC enthesis mechanical properties.55 Additionally, diabetes increased post-operative complications, such as infections and failures after RC repairs, while hypercholesterolemia increased tendon-related pathologies.56,57 (V) Obesity demonstrated inferior mechanical properties and poorer histological outcomes with high fat diet.58 This suggests that long-term maintenance of dietary intake to manage lipid levels and blood glucose prior to injury might have a positive influence on the healing process. (VI) Contrasting evidence exists regarding the effect of vitamin D levels on RC enthesis healing. Animal studies suggest a negative influence of low vitamin D on RC repair, while clinical trials found no correlation between vitamin D levels and retear rates.59,60 However, a large clinical study of arthroscopic RC repair found bone mineral density to be a reliable indicator of RC recovery.61 (VII) Non-steroidal anti-inflammatory drugs: they negatively affect healing in the acute post-operative stage for up to 6 weeks, while positively on remodelling of collagen matrix in chronic stages.62,63
Methodology
An electronic database search was performed using UCL's Online Library Service and PubMed. Keywords used were “enthesis AND rotator cuff”, “rotator cuff AND tear”, “rotator cuff OR enthesis”, “tissue engineering AND rotator cuff”, “stem cells AND rotator cuff enthesis”, and “growth factors AND rotator cuff enthesis”. Outcomes of in-vivo, in-vitro, and clinical studies on RC enthesis repair involving various tear extent, mechanism, chronicity, and population studies were also included. Exclusion criteria included other types of entheses, and surgical and rehabilitative interventions.
A total of 59 relevant studies were found after exclusion criteria were applied. Of these, 45 presented positive, 10 negative, and 4 mixed findings.
Literature was then summarised based on three main interventions: stem cells, GFs, and scaffolds. Findings were then categorised into groups according to their findings and methodologies (acute-full, chronic-full, acute-partial, chronic-partial, in aging and younger populations, and in-vitro studies). Figure 1 summarises the methodology process.
Figure 1.

Figure 1. A flowchart representing selection stages of the studies for their inclusion in the literature review.
Literature Review Findings
Cells and rotator cuff enthesis healing
Various stem cells such as mesenchymal stem cells (MSCs), adipose-derived stem cells (ADSCs), and bone marrow MSCs (BMSCs) are under investigation for potential use in enthesis regeneration.64
Mesenchymal stem cells
RC enthesis repairs could benefit from MSCs' capacity for self-renewal and multipotency, their availability, accessibility, and low immunogenicity.65 Moreover, MSCs' local synthesis of GFs may improve the environment for healing.66 Animal model studies have proven MSCs' potential for increasing ultimate load failure and resistance to mechanical deformation, enhancing bone quality, and attracting new fibrocartilage formation at the repaired site.67 Additionally, exogenous hyaluronic acid and MSCs have been showing promising potential to reduce retears.68
Bone marrow mesenchymal stem cells
BMSCs enhanced structural integrity of the repair and decreased the risk of retears in a chronic full tear cohort that underwent arthroscopic RC surgery with repeated channelling.69 Moreover, partial tear BMSC-enhanced repairs and prevented retears in 10-year follow-ups.70 Additionally, arthroscopy surface holding with BMSC stimulation increased RC repair integrity in large chronic tears.71 BMSCs stimulated by bioactive factors were more effective in promoting tissue regeneration. Platelet-rich plasma (PRP)-infused BMSCs improved GF production, osteogenic differentiation capacity, cell death resistance in-vitro, and biomechanical properties of newly formed bone in-vivo.72 Conversely, structure, composition, and strength of the repaired enthesis remained unchanged, despite BMSCs being present and active metabolically.73 However, this may be due to the short time taken to conduct the study, since stem cells require a longer time to be effective.74 Moreover, adenoviral MT1-matrix metalloproteinase (MMP)-augmented MSCs resulted in better fibrocartilage formation, and higher ultimate load and stress to failure after 4-week repair of acute full tears, while long-term effects require further research.75
Adipose-derived stem cells
ADSCs have a comparable shape and expression of the cluster differentiation surface marker protein to BMSCs with greater colony-forming and adipogenic capacity. They demonstrated multipotency in-vitro; developing into adipose, osteogenic, chondrogenic, and myogenic cells.76 Four groups were compared in a chronic full rabbit repair model: saline + suture, suture + ADSCs, saline, and ADSCs. ADSC and saline groups failed to heal, while suture + ADSCs group had a larger load to failure and less fatty infiltration than saline + suture group.77 Moreover, ADSCs imbedded in a fibrin sealant resulted in superior histological and biomechanical outcomes, in acute full murine RC repairs.78 As for the ideal location to deliver cells, regeneration was found most effective when stem cell sheets were interposed at the enthesis, in chronic full tears.79
In contrast, ADSCs in acute and chronic rat RC reconstruction models did not enhance biomechanical characteristics. However, inflammation was reduced, which could potentially lead to a more elastic repair and less scar formation after the healing process.80 Furthermore, TGF-β3 supplementation did not enhance ADSCs' effect on healing, despite its known role in the development of the enthesis.81 The absence of other mediators that are present during development and the presence of inflammatory mediators may have affected the bioactivity of TGF-β3 at the repair time. However, this study did not measure healing at different time points and ADSCs were not labeled to permit analysis of cell retention.
Due to contradictory evidence, it is unclear whether ADSCs constitute a good option to speed RC tendon-bone healing. To demonstrate its value in RC healing, more animal and clinical research is required. Additionally, challenges of availability, seeding, survival, and specificity of such therapies and the ethical regulatory barriers are yet to be overcome for this to reach a clinical trial. Table 1 summarises the findings.
Table 1. Summary of cell-based therapies literature findings
Author | Study | Model | Tear | Intervention | Outcome measure | Results |
---|---|---|---|---|---|---|
Honda et al.68 | In-vivo | Rabbit | Chronic full | MSC + HA | Biomechanical, histological, and immunohistochemical analyses | Positive: Improved ultimate load and faster healing |
Jo et al.69 | Clinical | Human | Chronic full | BMSC + arthroscopic repeated channeling | Pain scale, ROM, muscle strength, patient satisfaction questionnaire, and functional scores. Structural integrity by MRI and CT | Positive: Enhanced structural integrity of the repair and decreased retears |
Hernigou et al.70 | Clinical | Human | Chronic partial | BMSC + arthroscopy | MRI | Positive: Faster complete healing/retear prevention |
Taniguchi et al.71 | Clinical | Human | Chronic partial | ASH + BMSC | MRI | Positive: Reduced retear rates/better integrity |
Han et al.72 | In-vitro, in-vivo | Rat | Acute full | PRP-infused BMSC | Expression of genes that related to tissue repair, bone formation, and tendon regeneration; | Positive: Stronger signals to angiogenesis, bone formation, and tendon generation in-situ |
Biomechanical assessment | Promoted healing in-vivo | |||||
Gulotta et al.73 | In-vivo | Rat | Acute full | BMSC | Biomechanical & histological analyses | Negative: No change in structure, composition, or strength |
Gulotta et al.75 | In-vivo | Rat | Acute full | MT1-MMP-transduced MSCs | Biomechanical & histological analyses | Positive: Better fibrocartilage formation, higher ultimate load and stress to failure, and higher stiffness |
Oh et al.77 | In-vivo | Rabbit | Chronic full | ADSC + suture | Electromyographic, biomechanical & histological analyses | Positive: Larger load to failure and less fat infiltration |
Chen et al.78 | In-vivo | Murine | Acute full | ADSC imbedded in fibrin sealant scaffold | Biomechanical & histological analyses | Positive: Better biomechanical strength and histological score |
Choi et al.79 | In-vivo | Rat | Chronic full | ADSC sheets interposed at the enthesis | Biomechanical & histological analyses | Positive: Successful complete regeneration and biomechanical strength |
Valencia Mora et al.80 | In-vivo | Rat | Chronic full | ADSC, ADSC + TGF-β3 | Biomechanical & histological analyses | Positive: Reduced inflammation |
Negative: Unchanged maximum load, elastic energy, mechanical deformation, and stiffness |
Note: ADSC: adipose-derived stem cell; ASH: arthroscopy surface holding; BMSC: bone marrow mesenchymal stem cell; CT: computed tomography; HA: hyaluronic acid; MMP: matrix metalloproteinase; MRI: magnetic resonance imaging; MSC: mesenchymal stem cell; PRP: platelet-rich plasma; ROM: range of motion; TGF: transforming growth factor.
Cell pathways and rotator cuff enthesis healing
Ihh signaling molecule
Ihh signaling is active during the initial phases of RC enthesis healing.29,82,83 Fibrocartilage production in an acute full rat RC repair model had higher numbers of Ihh chondrocyte-like cells with MSC augmentation. Increased GLI family zinc finger 1 (Gli1) and Patched1 expression suggests that Ihh signaling pathway controls fibrocartilage production process brought on by stem cells. While both are expressed in fibroblasts of the tendon mid-substance, Ihh is primarily expressed in chondrocytes of the fibrocartilage region, which may indicate a coordinated interaction between chondrocytes and fibroblasts during healing.82 Additionally, immature mice with acute partial tears had a better recovery than adult mice due to the increased density of Gli1+ cells near the injured enthesis, mimicking its natural developmental process.83
Parathyroid hormone related protein
Parathyroid hormone (PTH) has been demonstrated to enhance tissue repair via a chondrogenic pathway.84,85 Osteoblasts speed up tendon-bone healing when PTH binds to its receptor in BMSCs during the tendon-bone healing process. Chen et al.86 showed that PTH may influence the tendon-bone healing process by maintaining the proliferation of BMSCs.
Daily systemic PTH injections boosted fibrocartilage development, type-I procollagen-producing cells, and vascularity, which improved collagen fibre structure and mineralised fibrocartilage production in acute full RC tears.87 Biomechanically, Duchman et al reported higher load to failure in recombinant human PTH-treated acute full RC tear rat model, and expression of intracellular and extracellular vascular endothelial growth factor (VEGF) with controlled recombinant human PTH systemic injections.88 Clinical investigations of advanced cases with chronic large tears achieved similar outcomes, and reduced retear rates.89 Table 2 summarises the findings.
Table 2. Summary of signaling molecules therapies literature findings
Author | Study | Model | Tear | Intervention | Outcome measure | Study results |
---|---|---|---|---|---|---|
Zong et al.82 | In-vivo | Rat | Acute full | Ihh + MSC | Immunohistochemical staining and proliferating cell nuclear antigen staining | Positive: Increased Gli1 and Patched1 expression. More organised and stronger staining for collagen II |
Schwartz et al.29 | In-vivo | Murine | Acute partial | Ihh | Lineage tracing | Positive: Gli1 lineage cells that originate in utero eventually populate the entire mature enthesis. Ablation of the Hh-responsive cells during the first week of postnatal development resulted in a loss of mineralised fibrocartilage |
Schwartz et al.83 | In-vivo | Mouse | Acute partial | Ihh | Lineage tracing | Positive: High levels of Gli1 expression in immature mice and mature entheses had fewer Gli1+ cells |
Hettrich et al.87 | In-vivo | Rat | Acute full | Systemic PTH | Histologic, immunohistochemical, biomechanical analyses | Positive: Higher stiffness, bone volume and mineral content; More fibrocartilage, osteoblasts, and blood vessels formation; Better collagen orientation |
Duchman et al.88 | In-vivo | Rat | Acute full | Systemic rhPTH | Biomechanical and histologic analysis | Positive: Higher load to failure. Expression of intracellular and extracellular VEGF |
Oh et al.89 | Clinical | Human | Chronic full | Systemic rhPTH | MRI, ROM, American Shoulder and Elbow Surgeons and Constant scores, and simple shoulder test | Positive: Lower retear rate |
Note: Gli1: GLI family zinc finger 1; Hh: hedgehog; Ihh: Indian hedgehog; MRI: magnetic resonance imaging; MSC: mesenchymal stem cell; PTH: parathyroid hormone; rhPTH: recombinant human parathyroid hormone; ROM: range of motion; VEGF: vascular endothelial growth factor.
Growth factors
GFs have been investigated to modulate stem cells in RC enthesis of small and large animal models.90⇓⇓⇓⇓⇓-96 Fibroblast growth factor 2 (FGF-2), growth differentiation factor, TGF-β3, and platelet-derived growth factor are commonly used examples.97⇓⇓⇓⇓⇓⇓-104 GFs such as BMP-12, -13, -14, basic fibroblast growth factor, cartilage oligomeric matrix protein, connective tissue growth factor, platelet-derived growth factor-B, and TGF-β1 have been found to be involved in enthesis healing process, one week after acute full rat supraspinatus repair. By 16 weeks, GF upregulation was back to pre-injury levels, indicating exogenous supplementation of these substances may encourage successful healing in acute stages.105 Angiogenesis and fibroblast proliferation are both powerfully stimulated by basic fibroblast growth factor. It continues to be strongly exhibited throughout the healing process, peaking at 7 and 9 days.106 Similar outcomes were attained in acute full sheep model RC tear, where BMP and VEGF induced angiogenesis and vasculogenesis, causing faster and better recovery.43,107
Studies investigated TGF-β3's potential to push scar-mediated healing to a regenerative one.108⇓⇓-111 Sustained delivery of TGF-β3 via a heparin/fibrin-based system in a rat model improved RC enthesis healing, while still inferior to an uninjured enthesis and disorganised scarring.110 Conversely, studies reported no improvement in biomechanical properties or scar reduction, with TGF-β3 and neutralising bodies for TGF-β1 and -β2 delivered via osmotic pumps, while inhibiting TGF-β1 improved RC enthesis quality by reducing fibrosis, fatty infiltration, and muscle atrophy.108,112 This however may be due to the delivery method used in the study, as antibodies were not delivered directly to the interface, rather to the bursal surface. Additionally, TGF-β1 release could compete for receptors with TGF-β3, which leads to reduced effectiveness of TGF-β3 treatment. A suggested solution is to combine TGF-β3 with a cytokine antagonist and TGF-β-neutralising antibodies or MMP inhibitors for acute full tears.32
Recombinant human FGF-18 was investigated for chondrogenic differentiation of BMSCs in a rat acute full tear model and enhanced regeneration in acute full RC tears.113 Furthermore, tumour necrosis factor (TNF) cytokine has been found to suppress chondrogenic stimulation via nuclear factor-kappa B by downregulating SRY-box 9 expression, whilst TGF-β3 solely was not ideal.114 While TNF inhibitor pegylated soluble TNF-R1 increased fibrocartilage and enhanced load to failure and stiffness, no improvement was seen past 8 weeks.115
Since loading after RC repairs is essential to prevent bone loss at the enthesis attachment, to achieve a mechanically resilient enthesis, collagen fibres within the tendon must attach to bone via mineralised fibrocartilage and remodel the underlying bone.30,116 Hence, osteoinductive factors (BMP-2–7) are used to induce chondrogenic differentiation and stimulate ECM component synthesis such as proteoglycans and collagen-II. Additionally, BMP-7 improved enthesis matrix maturation in gelatin hydrogel sheets of acute full RC tears.117,118 Conversely, Rodeo et al.107 implanted TGF-β1–3, BMP-2–7, and FGF in a collagen I matrix sponge and compared it to collagen sponge alone, in a sheep acute RC repair. While the study reported greater bone, fibrocartilage, and soft tissue formation, stiffness was less than collagen sponge only group.107 Although frequently having superior mechanical properties compared to controls, GF-enhanced repairs lack identical biomechanical qualities as native entheses.
GF temporal expression
Despite being present in all stages of healing, GF signal different pathways with different cell types during each stage. BMP-12, -13, -14, bFGF, connective tissue growth factor, platelet-derived growth factor, TGF-β1, and cartilage oligomeric matrix protein-1 are upregulated at the initial inflammatory stage, and subside by 16 weeks.105 The delay of TGF-β1 upregulation at 8 weeks is correlated with scar formation process.119 However, BMP-12 is expressed during all three phases, with a marked increase at eight weeks of remodelling stage. This highlights GF temporal expression involved in various stages of healing, which is essential in developing GFs delivery devices that can be introduced to spatiotemporally target RC repairs. Since healing process is regulated by multiple GFs, targeting one is not ideal functionally or mechanically.105 Table 3 summarises the findings.
Table 3. Summary of growth factor-based therapies literature findings
Author | Study | Model | Tear | Intervention | Outcome measure | Study results |
---|---|---|---|---|---|---|
Würgler-Hauri et al.105 | In-vivo | Rat | Acute full | BMP-12-14, bFGF, COMP, CTGF, PDGFB, TGF-β1 | Immunohistochemical staining | Positive: Increase in the expression of all GFs at 1 week, and followed by a return to control or undetectable levels by 16 weeks |
Kobayashi et al.106 | In-vivo | Rabbit | Acute full | BMP-12-14, bFGF, COMP, CTGF, PDGFB, TGF-β1 | Light microscopy after staining with hematoxylin-eosin and Elastica-Masson; Immunohistochemical staining | Positive: GFs are involved in early phases of healing promotion |
Rodeo et al.107 | In-vivo | Sheep | Acute full | BMP and VEGF | MRI, plain radiographs, histologic analysis, and biomechanical testing | Positive: Greater formation of new bone, fibrocartilage, and soft tissue, with an increase in tendon attachment strength |
Angeline and Rodeo43 | In-vivo | Sheep | Acute full | BMP and VEGF | Histologic analysis | Positive: Induced angiogenesis and vasculogenesis. Faster and better recovery |
Manning et al.110 | In-vivo | Rat | Acute full | TGF-β3 | Histologic and biomechanical analyses | Negative: Disorganised scar and inferior mechanical properties |
Kim et al.108 | In-vivo | Rat | Acute full | TGF-β3 | Histologic and biomechanical analyses | Negative: Disorganised scar and inferior mechanical properties |
Davies et al.112 | In-vivo | Mouse | Acute full | Inhibiting TGF-β1 | Histologic analysis | Positive: Reduced fibrosis, fatty infiltration, and muscle atrophy |
Jensen et al.32 | In-vivo | Mouse | Acute full and partial | TGF-β3 + cytokine + MMP inhibitors | Reviewing the literature | Positive: Enhanced healing |
Zhou et al.113 | In-vivo | Rat | Acute full | rhFGF-18 | Histologic analysis | Positive: Promoted chondrogenesis and promoted healing and regeneration |
Sitcheran et al.114 | In-vivo | Mouse | Acute full | TGF-β3 | Histologic analysis | Negative: No improvement in healing |
Gulotta et al.115 | In-vivo | Rat | Acute and chronic full | TNF inhibitor | Histologic and biomechanical analyses | Positive: Elevated fibrocartilage, and enhanced load to failure and stiffness |
Dorman et al.117 | In-vivo | Mouse | Acute full | BMP-2-7 | Histologic analysis | Positive: Fully healed enthesis without toxicity |
Kabuto et al.118 | In-vivo | Rat | Acute full | BMP-2-7 | Histologic and biomechanical analyses | Positive: Improved biomechanical properties |
Note: bFGF: basic fibroblast growth factor; BMP: bone morphogenetic protein; COMP: cartilage oligomeric matrix protein; CTGF: connective tissue growth factor; GF: growth factor; MMP: matrix metalloproteinase; MRI: magnetic resonance imaging; PDGF: platelet derived growth factor; rhFGF: recombinant human fibroblast growth factor; TGF: transforming growth factor; TNF: tumour necrosis factor; VEGF: vascular endothelial growth factor.
Scaffolds and augments
Augmentations via ECM or synthetic materials could potentially optimise RC enthesis healing.120 Allografts, synthetic polymers, autografts, and xenografts have been used for RC repairs.121 Despite improvements in xenografts and allografts decellularisation procedures, they still carry the risk of infection and inflammatory responses from residual donor DNA, high degradation rates, inferior mechanical qualities, and non-specific induction abilities.43 These concerns have sparked an interest to create grafts and scaffolds for enhanced repairs. Engineered scaffolds with a mix of natural and synthetic biomaterials offer an alternative solution to combat adverse effects caused by synthetic materials. Natural biomaterials including fibrin, collagen, elastin, and hyaluronic acid offer extracellular signals that facilitate cell infiltration and tissue regeneration, where positive results with good host tissue integration, remodelling, and improvement in biomechanical qualities are reported in animal trials employing them.122,123 Known to selectively differentiate BMSCs to chondrocytes, and gelatin methacrylol, a novel biomaterial with promising results in drug carrying, enhanced healing. kartogenin-loaded gelatin methacrylol hydrogel scaffold with bone marrow stimulation promoted fibrocartilage formation and resulted in superior mechanical properties in acute full RC repairs.124 Compared to traditional double row suture repairs, engineered tissue grafts with 6 months follow-up showed 11% increased elastic modulus, the repaired enthesis was formed similarly to the native tissue, suggesting potential long-term retear prevention.93
Exosome-delivered BMP-2 and polyaspartic acid in an acute full RC tear rabbit model resulted in increased tissue mineral density and ultimate load strength, via Smad/RUNX2 signaling pathway. Additionally, tendon regeneration- and cartilage differentiation-related expressions were upregulated, suggesting the positive potential of using bioactive scaffolds in enthesis healing.125 Since stem cells contribute to healing by autocrine/paracrine signaling through GFs and cytokines, delivering GFs via scaffolds is a simpler and more direct approach to improve RC healing. While interleukin-1 beta inhibited chondrogenesis and maturation of MSCs, the mechanical functionality of the tissue was preserved with three-dimensional (3D) woven polycaprolactone scaffolds.126 Highlighting the importance of developing strategies to protect against the deleterious effects of cytokines.
A novel strategy combined a 3D printed polylactide-co-glycolide acid scaffold with a cell-laden collagen hydrogel to fabricate layered structures. Mechanical properties improved supporting growth, proliferation, tenogenic differentiation of human ADSCs, and excellent biocompatibility.127
As for clinical studies, long-term effect of a polypropylene patch was assessed on large chronic RC repairs and compared with collagen patches, in a patient cohort of 66-year-old. Results showed superior outcomes in muscle strength, pain score, and tendon integrity via ultrasound after a 3-year follow-up.128 Repairs augmented with 3D biological collagen-I mesh in moderate and large RC tears of patients over 50 years, followed-up for 24-month resulted in better arranged collagen fibres, inflammatory cells less infiltrated, and lower RC retears at 17%.129
In general, scaffolds provide a growth microenvironment for cells and can be used as carriers for seeded cells and GFs, creating optimal conditions for RC enthesis healing. However, those technologies are still tackling the formation of fibrous cartilage, inflammatory reactions, elevated degeneration rates of the grafted scaffolds, and long-term follow-up.
Demineralised bone matrix
Demineralised bone matrix (DBM) is cancellous bone with osteoinductive and osteoconductive characteristics, known to elicit good adhesion, proliferation, and differentiation of MSCs.133 DBM-based repairs have not been consistent in improving collagen organisation and fibrocartilage formation, nor result in higher bone mineral density.134 However, supplementing them with BMSCs resulted in superior outcomes in chronic full tears.135 Additionally, the use of DBM-based sponge hydrated with PRP resulted improved strength and histological structure in chronic full tears.136 Despite this, when evaluating the clinical outcomes of patients undergoing biologically enhanced DBM-augmented RC repairs, 50% of patients' magnetic resonance imaging (MRI) confirmed supraspinatus failure.137
A more recent study fabricated a gradient multi-tissue construct that mimics structural, compositional, and cellular heterogeneity of the native enthesis designed by 3D cell-printing and tissue-specific decellularised ECM bioinks, where findings suggested improvement in restoring shoulder function.138 The first human pilot study was performed to assess the safety and efficacy of autologous dermal fibroblast (ADF) injections on full chronic RC repairs of patients aged 20-80 years. Fibroblast samples were obtained from the patients' gluteal region and cultured for four weeks. Patients from both, the control group who did not have an ADF injection, and experimental group, underwent standardised post-operative rehabilitation program involving ice application for 5 days and tramadol for a week, alongside abduction brace immobilisation for five weeks. Exercises such as shoulder shrug and active elbow and forearm range of motion were encouraged immediately after surgery. 10-12 weeks after surgery active-assisted, active range of motion, and strengthening exercises were performed, with return to sport allowed after 6 months. Successful healing without adverse effects was reported in 1-year follow-up.139 However, this study was limited by the small number of participants and the optimal dosage of ADF was not established. It is difficult to conclude the effectiveness of DBM-based augments on the overall healing process. Larger studies are necessary to examine its true effectiveness and long-term effect.
Platelet-rich plasma
PRP provides a rich source of GFs and cytokines such as PDGF, TGF-β, FGF, VEGF, and IGF.140 In a study comparing the clinical and structural outcomes between arthroscopic repair of full thickness RC tears with and without PRP supplementation, retear rates were lower with PRP in tears greater than 3 cm, with improved Constant score.141 Conversely, platelet-rich fibrin clot matrix, a variant of PRP with a fibrin matrix showed no difference in tendon thickness and greater tuberosity coverage in chronic full tears, and positive outcomes in partial tears.142 However, this could be due to variable PRP preparation used, the nature of PRP used, and level of platelet activation not being accounted.143 Thus, future research should focus on controlled PRP formulations to judge the benefits of this intervention more accurately.
Systematic reviews revealed PRP injections intraoperatively to produce better long-term pain and shoulder function outcomes following repairs in chronic full tears. While for short-term follow-ups, PRP was superior in improving function only, in partial RC tears.144⇓⇓-147 Post-operative subacromial PRP injections on patients with partial RC tears revealed improvement in functional outcomes up to 6 months, despite magnetic resonance imaging structural outcomes being insignificant, and long-term follow-up not being recorded.148 Moreover, PRP combined with sodium hyaluronate yielded better outcomes in partial RC tears in younger population after 12 months of follow-up.149 Recent meta-analyses showed PRP augments with double-row constructs have the best outcomes for chronic full tears, according to visual analogue scale (VAS), Constant, Simple Shoulder Test and retears.150,151
Ilhanli et al.152 debated that PRP may be as effective as physiotherapy interventions in patients with chronic partial tears followed up for 12 months. Despite a study showing an increase in PRP concentration after exercise, it remains unknown whether physiotherapy could enhance the effect of PRP.153 Moreover, the literature varies in terms of exercise type, intensity, and duration for RC tears.154 Standard rehabilitation protocols and ideal platelet concentrations for PRP augmented repairs are essential to preserve outcomes and create tailored care for patients with different backgrounds and abilities.
PRP is considered a suitable alternative to corticosteroid injections, which are commonly used clinically to manage RC tears. Achieving pain relief and good clinical outcomes add to the benefit of avoiding the adverse effects of corticosteroids on the body, which makes it an alternative approach to managing symptomatic RC tears, in both; young and athletic, and older populations with comorbidities. Table 4 summarises the findings.
Table 4. Summary of scaffold-based therapies literature findings
Author | Study | Model | Tear | Intervention | Outcome measure | Study results | ||
---|---|---|---|---|---|---|---|---|
Huang et al.124 | In-vivo | Rabbit | Acute full | KGN-loaded GelMA hydrogel + BMSC scaffold | Macroscopy, microcomputed tomography, histology, and biomechanical tests | Positive: Promoted fibrocartilage formation and superior mechanical properties | ||
Novakova et al.93 | In-vivo | Sheep | Acute full | Engineered tendon construct with BMSCs | X-ray and biomechanical tests | Positive: Native-like enthesis with higher modulus | ||
Han et al.125 | In-vivo | Rabbit | Acute full | BMP-2 + polyaspartic acid + Smad/RUNX2 signaling | Transmission electron microscopy staining; Biomechanics and histological assessment | Positive: Increased bone and tissue mineral density and ultimate load strength | ||
Ousema et al.126 | In-vitro | RC tear | 3D woven PCL scaffold + IL-1 inhibition on MSCs | Histological, biomechanical, and immunohistochemistry analyses | Positive: Mechanical functionality preserved with the use of a 3D woven PCL scaffold | |||
Jiang et al.127 | In-vitro | RC tear | 3D PLGA scaffold + a cell-laden collagen hydrogel + ADSCs | Histological and biomechanics analyses | Positive: Improvement in mechanical properties and biocompatibility | |||
Iannotti et al.131 | Clinical | Human | Chronic full | SIS | Penn shoulder-score questionnaire and MRI | Negative: No improvement in healing and clinical results | ||
Malcarney et al.132 | Clinical | Human | Chronic full | SIS | Study discontinued due to adverse effects | Negative: Inflammatory reaction | ||
Sclamberg et al.130 | Clinical | Human | Chronic full | SIS | Patient questionnaire, MRI, and ASES | Negative: No improvement and worse pot-operative outcomes | ||
Ciampi et al.128 | Clinical | Aging human | Chronic full | Polypropylene augmentation patch | Ultrasound, muscle strength, and VAS | Positive: Improved muscle strength, pain score, and tendon integrity | ||
Cai et al.129 | Clinical | Aging human | Chronic full | 3D biological collagen-I mesh | MRI, VAS, UCLA SST, and Constant score | Positive: Less retear rates | ||
Hoberman et al.133 | In-vitro | RC tear | DBM + BMSCs + PRP | Adhesion, proliferation, and differentiation assays | Positive: Better adhesion, proliferation, and differentiation | |||
Thangarajah et al.134 | In-vivo | Rat | Chronic full | DBM | Histological analysis | Negative: No improvement in collagen organisation and fibrocartilage formation | ||
Thangarajah et al.135 | In-vivo | Rat | Chronic full | DBM + MSCs | Histological analysis | Positive: Enhanced healing | ||
Smith et al.136 | In-vivo | Canine | Chronic full | PRP + DBM | Histological and biomechanical analysis | Positive: Improvement in strength and histological structure | ||
Wellington et al.137 | Clinical | Human | Chronic full | DBM + MSCs | MRI | Negative: Supraspinatus failure | ||
Chae et al.138 | In-vivo | Mouse | Chronic full | 3D cell-printed tendon-bone interface construct | >Gait analysis, histological and biomechanical analysis | Positive: Fully formed enthesis, improved shoulder outcome and biomechanical properties | ||
Yoon et al.139 | Clinical | Aging and young human | Chronic full | ADF | ROM, VAS, and MRI | Positive: No adverse effects, improved VAS, and functional scores | ||
Warth et al.141 | Clinical | Human | Chronic full | PRP | MRI and Constant score | Positive: Lower retear and improved constant score | ||
Castricini et al.142 | Clinical | Human | Chronic partial | Autologous PRFM | MRI | Positive: Improved tendon integrity | ||
Chronic full | Autologous PRFM | MRI | Negative: No difference in constant score and tendon integrity | |||||
Giovannetti de Sanctis et al.144 | Systematic review | Human | Chronic partial | PRP | Shoulder function and VAS | Positive: Improved pain and shoulder function | ||
Von Wehren et al.145 | Clinical | Human | Chronic partial | PRP | MRI, Constant score, ASES, shoulder ROM, and VAS | Positive: Improved pain and function | ||
Xu and Xue146 | Systematic review | Human | Chronic full | PRP | Retear rate, Constant, UCLA, ASES, VAS, and adverse effects | Positive: Improved shoulder outcome and reduced retear rate | ||
Rha et al.147 | Clinical | Human | Chronic partial | PRP | Shoulder Pain and Disability Index, ROM, and ultrasound | Positive: No adverse effects, and improved shoulder pain and function | ||
Shams et al.148 | Clinical | Human | Chronic partial | PRP | MRI, ASES, Constant Score, SST, and VAS | Positive: Improved shoulder function and minor MRI improvement | ||
Cai et al.149 | Clinical | Young human | Acute partial | SH + PRP | VAS, Constant score, and MRI | Positive: Better VAS, constant score, and MRI findings | ||
Ryan et al.150 | Systematic review | Human | Chronic full | PRP | Constant, ASES, UCLA, SST, VAS, and retear rate | Positive: Reduced retear rates and improved clinical outcomes | ||
Lavoie-Gagne et al.151 | Systematic review and meta-analysis | Human | Chronic full | PRP | Clinical characteristics, retear rates, ROM, and patient reported outcomes | Positive: Reduced retear rates and improved clinical outcomes | ||
Ilhanli et al.152 | Clinical | Human | Chronic partial | PRP | ROM, VAS, Disabilities of Arm, Shoulder and Hand questionnaire, Neer's, Hawkins' and drop arm tests and Beck Depression Inventory questionnaire | Negative: Results were not superior to physiotherapy |
Note: 3D: three-dimensional; ADF: autologous dermal fibroblast; ADSC: adipose-derived stem cell; ASES: American Shoulder and Elbow Surgeons; BMP-2: bone morphogenetic protein-2; BMSC: bone marrow mesenchymal stem cell; DBM: demineralised bone matrix; GelMA: gelatin methacrylol; IL-1: interleukin-1; KGN: kartogenin; MRI: magnetic resonance imaging; PCL: polycaprolactone; PLGA: polylactide-co-glycolide acid; PRFM: platelet-rich fibrin clot matrix; PRP: platelet-rich plasma; RC: rotator cuff; ROM: range of motion; SH: sodium hyaluronate; SIS: small intestine submucosa; SST: Simple Shoulder Test; UCLA: University of California Los Angeles; VAS: visual analogue scale.
Biomechanical Loading Response
Loading tendons is critical for the maintenance of developing entheses, and tissue deformity, delayed mineralisation, and porous non-mineralised tissues are observed when unloaded. Mechanical stimulation increases TGF-β1 and Prrx1+ cells to stimulate enthesis repair.155 Unloading affects chondrocyte hypertrophy, leading to fibrocartilage absence at the insertion by eight weeks of immobilisation.36 Reduced humeral volume with flatter surface and morphological changes comparable to those with cerebral palsy were noted, which is attributed to an increase in osteoclasts activity. Hence, blocking osteoclasts activity by bisphosphonate drugs partially recovers bone mineralisation and volume.36,37 This imbalance, therefore, contributes to developing an overall mechanically inferior tissue.
While prolonged and immediate mechanical loading induced adverse effects, low-intensity loading was beneficial as opposed to complete removal.156⇓-158 Since immediate excessive and prolonged loading produce adverse effects, and removal causes malformation, a requirement for balance between loading and healing is essential. When compared to various rehabilitative regimens, simple progressive loading is ideal.159
Discussion
RC tears are one of the most common causes of pain and dysfunctions in the shoulders, occurring in 9% under the age of 20 years to 62% until 80 years old.160 Overhead-sport athletes are at higher risk of chronic RC injuries, due to repetitive loads leading to microtraumas, while contact-sport athletes have a higher risk of traumatic acute tears.161 As for the aging population, degenerative pathologies are the most prevalent mechanism of injury.162 Older patients with chronic tears would benefit from non-operative approaches, and younger athletes presenting acute tears require surgery, due to expectations of returning to competition. However, competitive athletes record lower return rates compared to recreational ones.163 The reason for this remains multifactorial and may not be directly related to the repair, but rather a result of psychological factors such as fear of injury reoccurrence.164,165
RC repairs present good short-term pain and function improvement, and high retears in the long-term.166 Failure of complete healing urges the shift to alternative strategies aiming at restoring the native tissue's structure and biomechanical properties. Since the RC enthesis is made of a variety of cellular components organised in a gradient complex ECM structure, its regeneration requires the co-regulation of multiple factors.167
Stem cell role
The effectiveness of using stem cells to promote RC enthesis healing lies in regulating the differentiation of stem cells into target cells. This regulation is affected by certain factors: (1) the interaction between cells, (2) GFs and signaling molecules in promoting their expression, and (3) local microenvironment and mechanical stimulation. Obtaining stem cells and their survival rate are issues faced when used for RC enthesis healing, hence, improving this can broaden their use in hypoxic conditions. Additionally, methods in which stem cells are taken from patients can reduce patient inconvenience.167
Growth factor role
GFs regulate RC enthesis healing in several ways: (1) different GFs are expressed in stages of healing, with GFs promoting angiogenesis present in the inflammatory stage, and those endorsing cell differentiation for collagen synthesis at the repair and remodelling stages.168 (2) As a signaling molecule, by promoting the expression of genes and proteins related to regulate the biological behavior of cells. (3) By interacting with other GFs. It is essential to consider that: (1) GFs have a short half-life, thus carriers to delay their local release rate and maintain their effect are essential. (2) GFs have different effects based on the tear type. (3) The role of some GFs and their signaling pathways remains unclear. Considerable variations persist between studies in the preparation of GFs (recombinant, synthetic), delivery methods (local injections, systemic, within scaffold, coated sutures), and timing (pre-, peri-, post-operative, and repeated dosages).
Scaffold's role
The choice of scaffold material should meet the growing needs of specific cells, simulate its ECM, mechanically support, and provide a suitable growth environment. Since the main component at the RC insertion is collagen, the application of biomaterials with collagen matrix as the main component is the most effective.92,129 Patches designs are essential to assure its proper interaction with the microenvironment for proliferation, adhesion, differentiation, and morphology.169⇓⇓-172
Summarised outcomes
Augmenting MSCs with adenoviral MT1-MMP had positive biomechanical outcomes in acute full tears75 (Figure 2). ADSCs present contradicting outcomes in acute and chronic full tears, and BMSCs were recorded as negative in acute.73,77,80,81 However infusing BMSCs with PRP and imbedding ADSCs in fibrin sealant scaffold enhance repairs.72,78 Conversely, TGF-β3-supplemented ADSCs did not enhance acute full tear healing.80 For chronic full ones, MSCs combined with hyaluronic acid, BMSCs with repeated channeling, and ADSC sheets interposed improved outcomes.68,69,79 Clinical trials in chronic partial tears with BMSC-enhanced augmentation improved healing and prevented retears.70,71
Figure 2.

Figure 2. Categorised literature findings: stem cells, GFs, and scaffolds vary in effect depending on the extent of the tear, chronicity level, population, and their combinations. Majority of studies investigated acute full tears, while less studies were investigating partial and full chronic tears. Very few studies considered the age of the studied population. 3D: three-dimensional; ADF: autologous dermal fibroblast; ADSC: adipose-derived stem cell; bFGF: basic fibroblast growth factor; BMP: bone morphogenetic protein; BMSC: bone marrow mesenchymal stem cell; COMP: cartilage oligomeric matrix protein; CTGF: connective tissue growth factor; DBM: demineralised bone matrix; GelMA: gelatin methacrylol; GF: growth factor; HA: hyaluronic acid; Ihh: Indian hedgehog; KGN: kartogenin; MMP: matrix metalloproteinase; MSC: mesenchymal stem cell; PCL: polycaprolactone; PDGFB: platelet-derived growth factor-B; PLGA: polylactide-co-glycolide acid; PRFM: platelet-rich fibrin clot matrix; PRP: platelet-rich plasma; PTH: parathyroid hormone; SH: sodium hyaluronate; SIS: small intestine submucosa; TGF: transforming growth factor; TNF: tumour necrosis factor.
For signaling molecules, systemic PTH produced positive outcomes in full acute and chronic tears.87⇓-89 Ihh with MSCs had positive outcomes in acute partial and full tears.29,82,83 BMP-12-14, basic fibroblast growth factor, COMP, connective tissue growth factor, PDGFB, BMP-2-7, recombinant human FGF-18, TGF-β1, and the combination of BMP and VEGF resulted positively, while TGF-β3 remained ineffective in acute full tears.43,105⇓ -107,110,113,114,117,118 Inhibiting TGF-β1 was effective in acute full tears, and TNF inhibition was better in full acute and chronic tears.112,115 Most promising outcomes were attained by combining TGF-β3 with a cytokine and MMP inhibitor in acute partial and full tears.32
Outcomes from scaffold-based studies are promising and reached clinical trials. Polypropylene augmentation patch resulted in good outcomes in aging models with chronic full tears.128 3D cell-printed tendon-bone interface construct revealed positive outcomes in chronic full tears contrasting small intestine submucosa.130⇓-132,138 Kartogenin-loaded gelatin methacrylol with BMSCs, engineered constructs with BMSCs, and BMP-2 with polyaspartic acid and Smad/RUNX2 improved acute full tears.93,124,125 DBM-based scaffold was not beneficial, however, augmenting it with MSCs and PRP in separate animal models was effective.134⇓-136 Clinical trials on DBM and MSCs combination did not replicate similar outcomes.137 This could be attributed to the varied forms of scaffold materials, since animal models have shown promising results with strips of cancellous DBM, while clinical studies used sponges. Sponges can be displaced from the interface site, whereas strips and patches can be more securely sutured into the interface.
Autologous platelet-rich fibrin clot matrix clinical studies were more beneficial in chronic partial than full tears.142 ADF was safe and effective in younger and older populations with chronic full tears.139 While PRP is proven beneficial in chronic partial and full tears, it wasn't superior to physiotherapy.126,141,144⇓⇓⇓ -148,150⇓ -152 Sodium hyaluronate combined PRP was effective in acute and partial tears of younger populations.149 3D collagen I mesh augmentation in older populations with chronic full tears resulted in positive long-term outcomes.129 Novel multifactorial lab-based tissue engineering strategies such as 3D-woven polycaprolactone scaffold with IL-1 inhibition on MSCs, 3D polylactide-co-glycolide acid scaffold in cell-laden collagen hydrogel and ADSCs, BMSCs and PRP enhanced DBM-based scaffold had promising outcomes.126,127,133
Potential reasons for variations
Outcomes vary since there is no standardised controlled environment prior and after repairs. They differ in methodologies, animal models, and mechanical follow-ups; some allow free mobilisation after repairs, while others impose treadmill walking regimens or restrict movement. It is difficult to determine if variations are due to the interventions, animal models, mechanical environment, or extent and mechanism of tears. Some studies created acute dissection or detachment, immediately injecting it with the examined substances prior to repairs. However, that does not represent the clinical acute and chronic mechanism of tear, as it does not allow time for the inflammatory process to take place; no blood supply restriction, enthesis degeneration, and fatty infiltration. Other studies subject animals to a treadmill regimen prior to the intervention to exhaust tendons and replicate overuse. Findings should be similar in both scenarios, to indicate that the intervention has a definitive outcome.173 Treadmill regimen does not ideally replicate injury process in athletes performing sports since childhood. Professionally trained athletes have a lower risk of RC injury compared to amateurs that lack proper loading techniques, healthy balanced diet, sleep routine, and psychological well-being. This might fit amateur athletes scenario who are exposed to improper unconditioned loading. Additionally, small animal models such as rats and rodents have a far better healing capacity than larger animals and humans. Their measures of success should not be solely determined based on morphology, but also the timeframe and long-term effects. Surgical techniques used also affect the outcome of biological therapies. Introducing stem cells via tunnels produced superior outcomes to surface repairs. Additionally, biomaterial patch that covered the repair addressed MSCs long-term survival.174⇓-176
Clinical outcomes are affected by patients' occupation, demographics, age, gender, comorbidities, and tear mechanism and extent. Moreover, patient outcome measures have a degree of subjectivity, affected by expectations and psychosocial well-being.
Conclusion
To take research of tendon-bone enthesis for RC tears forward, there are critical factors involved in the healing of the enthesis, which is supported by what has been presented and rationale for, where without them there wouldn't be a successful healing. Tissue engineering has promising outcomes in achieving the complex RC enthesis structure and function. Different cells and GFs at specific times and environmental control can maximise the restoration of the native enthesis. Despite the positive outcomes of tissue engineering strategies, progressive loading environment is essential for optimum healing. Although the effects of the discussed interventions have mostly been confirmed in animal experiments, the intrinsic connections between cells at the interface and the molecular signaling pathways involved in tissue repair and regeneration still need to be further explored in humans. Nevertheless, the limitations mentioned are important to be considered for future studies to be applied in clinical practice.
This paper described the microscopic anatomy of the healthy RC enthesis, its role in facilitating force transmission, and the biomechanical adaptations. It then discussed the structural changes that accompany injured RC enthesis and the factors influencing its healing potential. Positive outcomes in the field of stem cells, GFs, and scaffolds along with their challenges, limitations, and variety of implementation are explained. The results support the proposed hypothesis that interventions should be tailored according to the tear extent, chronicity, and population studied.
Study limitations
Inconsistencies in reported outcomes derive from variations in patients' occupation, demographics, age, gender, comorbidities, and tear mechanism and extent. Moreover, patient reported outcome measures are subjective, and influenced by expectations and psychosocial well-being. Perspective studies would benefit from addressing the following:
1. The difficulties in advancing in vivo studies to clinical trials and the regulatory constraints associated with utilising biological interventions which have proven successful in the former, to the latter;
2. Biological materials availability and manufacturing in forms that can be utilised clinically in RC repair.
3. The potential for personalised biological intervention materials.
4. Solutions for aging patients and professional athletes requiring 100% recovery to return to competition.
5. Influential medical, environmental, social, and psychological factors.
Author contributions
Both authors contributed to the design, literature research, analysis, and preparation of the manuscript. Both authors revised the manuscript and approved the final version of the manuscript.
Financial support
None.
Acknowledgement
Ahlam A. Abdalla would like to extend my gratitude to Dr. Catherine Pendegrass for encouraging and supporting me throughout. We appreciate UCL for providing the resources and easy access to the literature, as it was essential to obtain the requirements and complete this paper. This review was supported by the United Arab Emirates Ministry of Education, and University College London.
Conflicts of interest statement
Both authors declare that they have no competing interests.
Open access statement
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.